Get short, timely messages from Pharmaceutical Field.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @PharmaField.

Get updates via SMS by texting follow PharmaField to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

PharmaField

  1. Study raises hopes for pancreatic cancer treatment: http://bit.ly/bjgVUc
  2. Got an event to promote to the UK pharma industry? Send it for inclusion in the new Pf website Events section.
  3. Executives optimistic about future of pharma: http://bit.ly/bx3RTe
  4. Novo Nordisk launches insulin dosing app: http://bit.ly/bDQXfG
  5. Cegedim study assesses rep quality: http://bit.ly/bITl9K
  6. Calls for UK Avandia withdrawal: http://bit.ly/aTV0ik
  7. @Boehringer Congratulations on your 125th Jubilee! Looks like it was a great party.
  8. Bohuon to be new Pierre Fabre CEO: http://bit.ly/bhQmKP
  9. Swine Flu vaccine under review: http://bit.ly/9ukV1n
  10. Drug reduces mortality risk by a quarter: http://bit.ly/de8l7q
  11. Brinavess secures EU approval: http://bit.ly/9XgI8A
  12. New centre will speed therapies from ‘bench to bedside’: http://bit.ly/aedUdA
  13. New EU drug approved for rare disease: http://bit.ly/chJKXO
  14. Can't quite believe the extent of the Pf Features archive! 11/12 editions a year for 10 years - that's a lot of content
  15. Duo recommended in draft guidance: http://bit.ly/cLTZOn
  16. NICE reverse backed by campaigners: http://bit.ly/9H90IQ
  17. Novartis gains majority stake in Alcon, but dispute with minority shareholders continues: http://bit.ly/a521kU
  18. NHS bonus scheme under review: http://bit.ly/brDcDO